ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Meta-analysis links vitamin D deficiency with increased risk of mortality during 10.5 year median pe...

Prevent Or Reverse Diabetes: An Amazing Herbal Intervention

Exercise and Vitamin D Better Together for Heart Health

VIDEO: Essential Oils for Weight Loss

Can Valerian Root Help You Sleep Better?

Can Ginkgo Give Your Brain a Boost?

Fighting Statin-Induced Diabetes with CoQ10

Eight servings of veggies a day is clearly best for the heart

The Many Wonders of Calming Sandalwood Oil

Curcumin — A Novel Treatment Alternative for Depression

 
Print Page
Email Article

NIMH Genetics Initiative Study Steers Alzheimer's Disease Research in New Direction

  [ 7 votes ]   [ Discuss This Article ]
By Press Release by the National Institute of Mental • www.ProHealth.com • April 24, 1997


NIMH investigators have found in a sample of Alzheimer's disease (AD)-prone families that the Apolipoprotein E-4 (apoE-4) gene may exert its most marked effect in those in whom the disease develops at age 70 or younger. However, in this largest genetic study of AD to date, the gene remained a significant risk factor even at later ages.

The apoE-4 gene confers increased risk of developing AD, suggesting that it plays a significant role in the disease process. One copy of apoE-4 moderately increases an individual's risk of developing AD, while two copies confer a higher risk. At least one copy of the apoE-4 gene is borne by about one-half of those with AD in general population-based surveys, and by only about one-quarter of those without the disease.

The findings from the new report reaffirm the importance of this gene in conferring risk for AD and suggest that it asserts its maximal effect before age 70, at least in the families studied in this project. Combined results of large population-based studies will be necessary to determine the overall age-related risk conferred by the apoE-4 gene.

This study is the latest to suggest that additional genetic factors likely play a role in later onset forms of the disease. Steven E. Hyman, M.D., Director of the National Institute of Mental Health, whose Genetics Initiative funded the study, said, "These results should steer scientists to look for additional genetic clues to the later onset, more common form of this terrible, mind-destroying disease."

The newly published research is remarkable for its sample size of 679 individuals in 310 families, which was large enough for the researchers to separate out individuals by age at onset of AD symptoms. Rudolph E. Tanzi, Ph.D., of Harvard's Massachusetts General Hospital, the senior author of the study, said, "It remains critical to search for additional genes involved in the development of late-onset AD."

The newly published research also shows that in the studied families, several individuals over 80, who were Alzheimer's-free, carried two copies of the apoE-4 gene. So, said Dr. Tanzi, it seems premature to offer apoE testing as the sole predictive test for AD. This position is consistent with that of two national panels that examined the practical considerations regarding genetic assessment for AD using apoE-4. However, said Dr. Tanzi, genetic research carries the greatest promise to ultimately clarify mechanisms leading to the development of AD. "In the future, reliable genetic tests for AD could be used to identify those who are most likely to develop the disease," he said. "In this complex disease, such genetic tests might have to take into consideration the combined effects of multiple risk factor' genes and, perhaps, other non-genetic risk factors."

Dr. Tanzi's Harvard collaborators on the study, published in the January issue of Neurology, were lead authors, Deborah Blacker, M.D., Sc.D., and Jonathan Haines, Ph.D., along with principal investigator Marilyn S. Albert, Ph.D.


Source: National Institute of Mental Health
Press Release
April 24, 1997



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Mitochondria Ignite™ with NT Factor® Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Could a B-12 Deficiency Be Causing Your Symptoms? Could a B-12 Deficiency Be Causing Your Symptoms?
The Fast-Acting Solution for Healthy Digestive Function The Fast-Acting Solution for Healthy Digestive Function
Herbal Rescue for High Blood Sugar Herbal Rescue for High Blood Sugar
How One Tiny Molecule Turned into One Huge Health Breakthrough How One Tiny Molecule Turned into One Huge Health Breakthrough
Anti-Inflammatory Properties of Tart Cherry Anti-Inflammatory Properties of Tart Cherry

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map